Schneyer named Acadia CBO; plus Hansa, MaaT, iOnctura, First Light, Oligomerix, Galecto and Hyloris

CNS disorders company Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) announced Mark Schneyer as its first CBO. He was VP, business development at the Upjohn unit of Pfizer Inc. (NYSE:PFE).

Hansa Biopharma AB (SSE:HNSA) said Achim Kaufhold will become CMO, a newly created position. Before joining the autoimmune company, he served Basilea Pharmaceutica Ltd. (SIX:BSLN) in the same role...